BiDil, a drug recently approved to treat heart failure in
African-Americans, may be useful for any heart failure patient. A
guide to the FDA's approval of the controversial drug.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.